Found: 4
Select item for more details and to access through your institution.
Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 7, p. 709, doi. 10.1111/1759-7714.14807
- By:
- Publication type:
- Article
Second‐line therapy with first‐ or second‐generation tyrosine kinase inhibitors in EGFR‐mutated non‐small cell lung cancer patients with T790M‐negative or unidentified mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 7, p. 1067, doi. 10.1111/1759-7714.13870
- By:
- Publication type:
- Article
Extensive calcification in adenocarcinoma of the lung: A case report.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 3038, doi. 10.1111/1759-7714.13637
- By:
- Publication type:
- Article
Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2970, doi. 10.3390/cancers14122970
- By:
- Publication type:
- Article